These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27035336)

  • 21. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).
    Kobayashi H; Saga T; Kawamoto S; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
    Cancer Res; 2001 Jul; 61(13):4966-70. PubMed ID: 11431325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
    Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
    Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
    Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
    Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical evaluation of the tumor-targeting properties of bispecific antibodies based on quantitative biodistribution data.
    Hemmerle T; Wulhfard S; Neri D
    Protein Eng Des Sel; 2012 Dec; 25(12):851-4. PubMed ID: 22972762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A tumor-penetrating recombinant protein anti-EGFR-iRGD enhance efficacy of paclitaxel in 3D multicellular spheroids and gastric cancer in vivo.
    Sha H; Li R; Bian X; Liu Q; Xie C; Xin X; Kong W; Qian X; Jiang X; Hu W; Liu B
    Eur J Pharm Sci; 2015 Sep; 77():60-72. PubMed ID: 25998561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
    Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
    Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
    Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
    Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
    Ye J; Xu YK; Liu X; Lü GS
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent.
    Asano R; Sone Y; Makabe K; Tsumoto K; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    Clin Cancer Res; 2006 Jul; 12(13):4036-42. PubMed ID: 16818703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability and trapping of magnetic resonance imaging contrast agents during high-intensity focused ultrasound ablation therapy.
    Hijnen NM; Elevelt A; Grüll H
    Invest Radiol; 2013 Jul; 48(7):517-24. PubMed ID: 23695082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple and inexpensive system for controlling body temperature in small animal experiments using MRI and the effect of body temperature on the hepatic kinetics of Gd-EOB-DTPA.
    Murase K; Assanai P; Takata H; Saito S; Nishiura M
    Magn Reson Imaging; 2013 Dec; 31(10):1744-51. PubMed ID: 24094686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
    Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
    J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrepancies between the fate of myoblast xenograft in mouse leg muscle and NMR label persistency after loading with Gd-DTPA or SPIOs.
    Baligand C; Vauchez K; Fiszman M; Vilquin JT; Carlier PG
    Gene Ther; 2009 Jun; 16(6):734-45. PubMed ID: 19282845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
    Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
    Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of tetravalent IgG1 dual targeting IGF-1R-EGFR antibodies with potent tumor inhibition.
    Croasdale R; Wartha K; Schanzer JM; Kuenkele KP; Ries C; Mayer K; Gassner C; Wagner M; Dimoudis N; Herter S; Jaeger C; Ferrara C; Hoffmann E; Kling L; Lau W; Staack RF; Heinrich J; Scheuer W; Stracke J; Gerdes C; Brinkmann U; Umana P; Klein C
    Arch Biochem Biophys; 2012 Oct; 526(2):206-18. PubMed ID: 22464987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity.
    Guo XF; Zhu XF; Shang Y; Zhang SH; Zhen YS
    Clin Cancer Res; 2010 Apr; 16(7):2085-94. PubMed ID: 20332319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.